Company Logo

duligotuzumab

Agricultural Biotechnology

Updated on Apr 8, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for duligotuzumab with ID of: 4160201
Fayette, J., Wirth, L., Oprean, C., Udrea, A., Jimeno, A., Rischin, D.,... & O’Brien, P. (2016). Randomized phase II study of duligotuzumab (MEHD7945A) vs. cetuximab in squamous cell carcinoma of the head and neck (MEHGAN Study). Frontiers in oncology, 6, 232.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.